In this study, we used a bioinformatics approach to evaluate the effect of NSP3 expression as well as genetic and epigenetic alterations on the TME with respect to tumor immune evasion mechanisms and prognoses in lung cancer cohorts. The gene discussed is SH2D3C; the disease is lung cancer.